Oncolytic adenovirus for treatment of malignant ascites
Mol Ther Oncolytics
.
2022 Aug 14:26:302-303.
doi: 10.1016/j.omto.2022.07.010.
eCollection 2022 Sep 15.
Authors
Akseli Hemminki
1
2
3
,
Camilla Heiniö
1
Affiliations
1
Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
2
TILT Biotherapeutics, Ltd., Helsinki, Finland.
3
Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
PMID:
36032634
PMCID:
PMC9399406
DOI:
10.1016/j.omto.2022.07.010
No abstract available
Publication types
Editorial